Some phytochemicals—magnolol, berberine, and ginsenosides have demonstrated potential to restore lysosomal acidification, enhance autophagic clearance, and modulate cathepsin activity, providing promising avenues for alleviating AD-related lysosomal dysfunction. The gene discussed is CTSS; the disease is Alzheimer disease.